Literature DB >> 31226575

Coagulation parameters predictive of polycystic ovary syndrome.

Qian Sun1, Yan Yang2, Xuenan Peng3, Yunyan Zhang2, Yuan Gao1, Fang Wang1, Yang Zhang1, Wen Feng1, Wen Yang4, Xiaomin Kang5.   

Abstract

OBJECTIVE: To explore coagulation parameters in association with polycystic ovarian syndrome (PCOS) and establish a model for predicting the risk of PCOS. STUDY
DESIGN: This study included 181 outpatients with PCOS. A total of 301 women who attempted to seek pre-pregnancy consultation at the Department of Gynecology of our hospital were included in the control group, and six coagulation parameters were measured for all included subjects. A logistic regression model was built based on the training dataset using the purposeful selection method to select important predictors. The performance of the established model was validated on the test dataset.
RESULTS: There were statistically significant differences found among all coagulation parameters except D-Dimer (DD, P = 0.080). The purposeful selection method selected age (odds ratio [OR] = 0.89; p = 0.008), prothrombin time (PT, OR = 0.68, p < 0.0001), thrombin time (TT, OR = 3.30; p = 0.0005), and fibrin degradation products (FDP, OR = 0.24; p = 0.0002) as important predictors of PCOS risk. The receiver operating characteristic (ROC) curve analysis indicated that the area under the ROC curve (AUC) of the model was 0.81 for the training dataset with an optimal cut-off point of the predicted probability of 0.45, leading to a sensitivity of 0.71 and a specificity of 0.82. The AUC was 0.79 for the test data.
CONCLUSIONS: It was found that the coagulation parameters, including PT, TT, and FDP, are predictive of PCOS. These results highlight the potential of anti-coagulation therapies to lower the risk of adverse outcomes in women with PCOS.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Coagulation; Endocrine disorder; Polycystic ovary syndrome; Prediction

Mesh:

Substances:

Year:  2019        PMID: 31226575     DOI: 10.1016/j.ejogrb.2019.06.018

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  2 in total

1.  Vitamin D association with coagulation factors in polycystic ovary syndrome is dependent upon body mass index.

Authors:  Alexandra E Butler; Stephen L Atkin; Abu Saleh Md Moin; Thozhukat Sathyapalan
Journal:  J Transl Med       Date:  2021-06-02       Impact factor: 5.531

2.  Metabolic consequences of obesity on the hypercoagulable state of polycystic ovary syndrome.

Authors:  Abu Saleh Md Moin; Thozhukat Sathyapalan; Ilhame Diboun; Mohamed A Elrayess; Alexandra E Butler; Stephen L Atkin
Journal:  Sci Rep       Date:  2021-03-05       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.